Venus Remedies successfully renews EU GMP certification, reinforcing its European market presence

Venus Remedies Limited has announced the successful renewal of its European Good Manufacturing Practices (EU GMP) certification. Granted by Infarmed, the National Authority of Medicines and Health Products in Portugal, this certification underscores the company’s unwavering commitment to delivering high-quality pharmaceutical products to the European market.


Key Highlights:

  1. Scope of Certification:
    • Covers the manufacturing facility for cephalosporin, carbapenem, and oncology (liquid and lyophilized injectable) formulations.
    • Validates Venus Remedies’ adherence to stringent quality and safety standards.
  2. European Market Leadership:
    • Venus Remedies has maintained a robust presence in Europe for over 15 years.
    • Recognized as one of the leading exporters of Meropenem outside India with multiple marketing authorizations across Europe.
  3. Commitment to Healthcare:
    • The renewal strengthens Venus Remedies’ position as a trusted partner for healthcare providers and patients.
    • Reinforces the company’s dedication to providing reliable and effective solutions.

Statement:

The company expressed its pride in achieving this milestone, emphasizing that the certification highlights its continuous commitment to quality and innovation in the pharmaceutical industry.

The EU GMP certification renewal is a testament to Venus Remedies’ excellence in pharmaceutical manufacturing and its sustained focus on delivering high-quality solutions to global markets. This achievement further solidifies its reputation as a trusted partner in the healthcare sector.